Form D · Biotechnology
Transcera Inc.
Jamaica Plain, MA · CIK 0001874184
Offering snapshot reported Nov 3, 2021 · SEC filing
- Reported sold
- $10K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 19, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 3, 2021 | Initial | $10,000 | No comparison | 1 | SEC filing |
| Jul 23, 2021 | Initial | $1,000,004 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-419628
Source: Form D, filed Nov 3, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Hunter Goble | Director, Executive |
| Phil Grayeski | Director |
| Wayne Lencer | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
60 Louders Lane
Jamaica Plain, MA, 02130
Jamaica Plain, MA, 02130